SI-BONE To Report Third Quarter 2026 Financial Results on November 2, 2026GlobeNewsWire · 5 days ago
Is SI-BONE Inc (SIBN) Overvalued After 3.8% Rally? GF Value Says OvervaluedGuruFocus · Oct 12, 2026
Analyzing SiBone (NASDAQ:SIBN) & Integer (NYSE:ITGR)Defense World · Oct 6, 2026
SI-BONE Receives FDA 510(k) Clearance for iFuse Granite Onyx™, Extending Its Compromised Bone Franchise Beyond the PelvisGlobeNewsWire · Sep 28, 2026
SI-BONE, Inc. (SIBN) Presents at Morgan Stanley 24th Annual Global Healthcare Conference TranscriptSeeking Alpha · Sep 14, 2026
SI-BONE To Present at Morgan Stanley 24th Global Healthcare Conference on September 14, 2026GlobeNewsWire · Aug 31, 2026SI-BONE, Inc. is a medical technology company that develops and markets specialized implantable solutions for musculoskeletal conditions affecting the sacropelvic region. These devices are utilized across the United States and internationally. Its flagship product, iFuse, is a minimally invasive surgical implant system designed to address a range of indications, including sacroiliac joint dysfunction and degeneration, adult spinal deformities, and traumatic fractures of the pelvic ring.
| Date | Est. | Actual | |
|---|---|---|---|
| Aug 3, 2026 | -$0.15 | -$0.09 | Beat |
| May 11, 2026 | -$0.17 | -$0.10 | Beat |
| Feb 23, 2026 | -$0.13 | -$0.04 | Beat |
| Nov 10, 2025 | -$0.16 | -$0.11 | Beat |
| Aug 4, 2025 | -$0.19 | -$0.14 | Beat |
| May 5, 2025 | -$0.24 | -$0.15 | Beat |